DSLT in Normal Tension Glaucoma (NTG) Asian Eyes
Part of paid clinical trials in San Jose, California.
- Sponsor
- Ngoc Nguyen Inc.
- Study ID
- NCT07300852
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Glaucoma
- Glaucoma, Open Angle
- Normal Tension Glaucoma (NTG)
- Open Angle Glaucoma (OAG)
Eligibility Criteria
- Sex
- ALL
- Age
- 20 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Direct Selective Laser Trabeculoplasty (DSLT) — DEVICEDirect Selective Laser Trabeculoplasty (DSLT) is a non-contact laser procedure that delivers energy to the trabecular meshwork without the need for a gonioscopy lens. The BELKIN Vision Eagle device automatically aligns and applies laser pulses to lower intraocular pressure in subjects with normal tension glaucoma. All participants receive a single DSLT treatment followed by routine post-procedure evaluations including IOP checks, visual field testing, and OCT imaging.
Study Details
The goal of this clinical trial is to evaluate the efficacy of direct selective laser trabeculoplasty (DSLT) or laser treatment in Asian patients with normal tension glaucoma. The main question it aims to answer is: Does the DSLT reduce intraocular pressure (IOP) and medication use in Asian NTG subjects? Participants will attend routine follow-up visits with their eye surgeon and glaucoma testing such as optical coherence tomography (OCT) imaging and visual field test(s) after the laser study treatment.
Key Dates
- Start date
- Jan 1, 2026
- Status verified
- Dec 2025
- Primary completion
- Jan 31, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: DSLT Treatment ArmParticipants will receive Direct Selective Laser Trabeculoplasty (DSLT) using the BELKIN Vision Eagle device. The procedure is performed without a contact lens and delivers non-contact laser energy to the trabecular meshwork to lower intraocular pressure. All participants undergo standard pre- and post-procedure evaluations, including IOP measurements, visual field testing, and OCT imaging.
Primary Outcome Measure
Change in Intraocular Pressure (IOP) [ Time Frame: 12 months post procedure ]
Central Contacts
- Ngoc Nguyen, M.D.4082723706
- Lauren Nguyen4086092569
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ngoc Nguyen M.D. | San Jose | California | 95116 |
Find similar trials in San Jose, CA
Related Studies
- Village-Integrated Eye Worker Trial IIRecruiting · University of California, San Francisco · San Francisco, California
- Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical MedicationsRecruiting · University of California, Los Angeles · Fountain Valley, California
- Topical Insulin for GlaucomaPHASE1 · Recruiting · Stanford University · Palo Alto, California
- Electrical Stimulation for the Treatment of Optic NeuropathiesRecruiting · Stanford University · Palo Alto, California